Recent Advances of D-α-tocopherol Polyethylene Glycol 1000 Succinate Based Stimuli-responsive Nanomedicine for Cancer Treatment

Abstract

D-α-tocopherol polyethylene glycol 1000 succinate (TPGS) is a pharmaceutical excipient approved by Chinese NMPA and FDA of USA. It’s widely applied as a multifunctional drug carrier for nanomedicine. The advantages of TPGS include P-glycoprotein (P-gp) inhibition, penetration promotion, apoptosis induction via mitochondrial-associated apoptotic pathways, multidrug resistant (MDR) reversion, metastasis inhibition and so on. TPGS-based drug delivery systems which are responding to external stimulus can combine the inhibitory functions of TPGS towards P-gp with the environmentally responsive controlled release property and thus exerts a synergistic anti-cancer effect, through increased intracellular drug concentration in tumors cells and well-controlled drug release behavior. In this review, TPGS-based nano-sized delivery systems responsive to different stimuli were summarized and discussed, including pH-responsive, redoxresponsive and multi-responsive systems in various formulations. The achievements, mechanisms and different characteristics of TPGS-based stimuli-responsive drug-delivery systems in tumor therapy were also outlined.

Keywords

D-α-tocopherol polyethylene glycol 1000 succinate / stimuli-responsive / nanomedicine / P-glycoprotein / cancer

References

[1] TanSW, ZouCM, ZhangW, et al.. Recent developments in d-α-tocopheryl polyethylene glycol-succinate-based nanomedicine for cancer therapy. Drug Deliv, 2017, 24(1): 1831-1842

[2] YangCL, WuTT, QiY, et al.. Recent advances in the application of vitamin E TPGS for drug delivery. Theranostics, 2018, 8(2): 464

[3] DuhemN, DanhierF, PreatV. Vitamin E-based nanomedicines for anti-cancer drug delivery. J Control Release, 2014, 182: 33-44

[4] GuoYY, LuoJ, TanSW, et al.. The applications of Vitamin E TPGS in drug delivery. Eur J Pharm Sci, 2013, 49(2): 175-186

[5] ZhangZP, TanSW, FengSS. Vitamin E TPGS as a molecular biomaterial for drug delivery. Biomaterials, 2012, 33(19): 4889-4906

[6] ZhengNN, WuLH, TangJL. Advance in Application of d-alpha-tocopherol polyethyleneglycol succinate in the field of pharmaceutics. Zhongguo Yaoxue Zazhi (Chinese), 2014, 49(16): 1373-1376

[7] DintamanJM, SilvermanJA. Inhibition of P-glyco-protein by D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS). Pharm Res, 1999, 16(10): 1550-1556

[8] SuRN, LiuTF, ZhuXM, et al.. Application of TPGS-based nano-drug delivery system in reversing P-gp mediated multidrug resistance. Yaoxue Xuebao (Chinese), 2018, 53(11): 1797-1807

[9] LiuTF, LiuXY, XiongH, et al.. Mechanisms of TPGS and its derivatives inhibiting P-glycoprotein efflux pump and application for reversing multidrug resistance in hepatocellular carcinoma. Polym Chem, 2018, 9(14): 1827-1839

[10] CollnotEM, BaldesC, WempeMF, et al.. Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: influence on ATPase activity and membrane fluidity. Mol Pharm, 2007, 4(3): 465-474

[11] CollnotEM, BaldesC, SchaeferUF, et al.. Vitamin E TPGS P-glycoprotein inhibition mechanism: influence on conformational flexibility, intracellular ATP levels, and role of time and site of access. Mol Pharm, 2010, 7(3): 642-651

[12] HaoTN, ChenDW, LiuKX, et al.. Micelles of d-α-tocopheryl polyethylene glycol 2000 succinate (TPGS 2K) for doxorubicin delivery with reversal of multidrug resistance. ACS Appl Mater Interfaces, 2015, 7(32): 18064-18075

[13] YuPC, YuHJ, GuoCY, et al.. Reversal of doxorubicin resistance in breast cancer by mitochondria-targeted pH-responsive micelles. Acta Biomater, 2015, 14: 115-124

[14] TuguntaevRG, ChenSZ, EltahanAS, et al.. P-gp inhibition and mitochondrial impairment by dual-functional nanostructure based on vitamin E derivatives to overcome multidrug resistance. ACS Appl Mater Interfaces, 2017, 9(20): 16900-16912

[15] WangDF, RongWT, LuY, et al.. TPGS2k/PLGA nanoparticles for overcoming multidrug resistance by interfering mitochondria of human alveolar adenocar-cinoma cells. ACS Appl Mater Interfaces, 2015, 7(7): 3888-3901

[16] WangAT, LiangDS, LiuYJ, et al.. Roles of ligand and TPGS of micelles in regulating internalization, penetration and accumulation against sensitive or resistant tumor and therapy for multidrug resistant tumors. Biomaterials, 2015, 53: 160-172

[17] CabralH, MiyataK, OsadaK, et al.. Block copolymer micelles in nanomedicine applications. Chem Rev, 2018, 118(14): 6844-6892

[18] FentonOS, OlafsonKN, PillaiPS, et al.. Advances in biomaterials for drug delivery. Adv Mater, 2018, 30(29): 1705328

[19] CagelM, TesanFC, BernabeuE, et al.. Polymeric mixed micelles as nanomedicines: Achievements and perspectives. Eur J Pharm Biopharm, 2017, 113: 211-228

[20] LombardoD, KiselevMA, CaccamoMT. Smart nanoparticles for drug delivery application: development of versatile nanocarrier platforms in biotechnology and nanomedicine. J Nanomater, 20191-26

[21] LuY, AimettiAA, LangerR, et al.. Bioresponsive materials. Nat Rev Mater, 2016, 2(1): 1-17

[22] FengAC, YuanJY. Smart nanocontainers: Progress on novel stimuli-responsive polymer vesicles. Macromol Rapid Commun, 2014, 35(8): 767-779

[23] ZhangWM, ZhangJ, QiaoZ, et al.. Functionally oriented tumor microenvironment responsive polymeric nanoassembly: Engineering and applications. Chin J Polym Sci, 2018, 36(3): 273-287

[24] LuCL, UrbanMW. Stimuli-responsive polymer nano-science: Shape anisotropy, responsiveness, applications. Prog Polym Sci, 2018, 78: 24-46

[25] ZhangXY, HanL, LiuMY, et al.. Recent progress and advances in redox-responsive polymers as controlled delivery nanoplatforms. Mater Chem Front, 2017, 1(5): 807-822

[26] StubbsM, McSheehyPMJ, GriffithsJR, et al.. Causes and consequences of tumour acidity and implications for treatment. Mol Med Today, 2000, 6(1): 15-19

[27] EnginK, LeeperDB, CaterJR, et al.. Extracellular pH distribution in human tumours. Int J Hyperthermia, 1995, 11(2): 211-216

[28] VanSR, BhujwallaZM, RaghunandN, et al.. In vivo imaging of extracellular pH using 1H MRSI. Magnetic Resonance in Medicine: An Official Journal of the International Society for Magnetic Resonance in Medicine, 1999, 41(4): 743-750

[29] MurphyRF, PowersS, CantorCR. Endosome pH measured in single cells by dual fluorescence flow cytometry: rapid acidification of insulin to pH 6. J Cell Biol, 1984, 98(5): 1757-1762

[30] SchmidS, FuchsR, KielianM, et al.. Acidification of endosome subpopulations in wild-type Chinese hamster ovary cells and temperature-sensitive acidification-defective mutants. J Cell Biol, 1989, 108(4): 1291-1300

[31] ZhouMX, ZhangXC, XieJ, et al.. pH-sensitive poly (β-amino ester) s nanocarriers facilitate the inhibition of drug resistance in breast cancer cells. Nanomaterials, 2018, 8(11): 952

[32] HungCC, HuangWC, LinYW, et al.. Active tumor permeation and uptake of surface charge-switchable theranostic nanoparticles for imaging-guided photo-thermal/chemo combinatorial therapy: erratum. Thera-nostics, 2017, 7(3): 559

[33] WangQ, ZouCM, WangLY, et al.. Doxorubicin and adjudin co-loaded pH-sensitive nanoparticles for the treatment of drug-resistant cancer. Acta Biomater, 2019, 94: 469-481

[34] HelmlingerG, SckellA, DellianM, et al.. Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism. Clin Cancer Res, 2002, 8(4): 1284-1291

[35] MiY, ZhaoJ, FengSS. Vitamin E TPGS prodrug micelles for hydrophilic drug delivery with neuroprotective effects. Int J Pharm, 2012, 438(1-2): 98-106

[36] KhareV, SakarchiWA, Gupta PremN, et al.. Correction: Synthesis and characterization of TPGS–gemcitabine prodrug micelles for pancreatic cancer therapy. RSC Advances, 2017, 7(21): 12598-12598

[37] GaoYH, PingQN, ZongL. Preparation and antitumor activity of mitoxantrone conjugated D-α-tocopherylpolyethylene glycol 1000 succinate prodrug micelle. Zhongguo Yaoke Daxue Xuebao (Chinese), 2016, 47(03): 311-316

[38] BaoYL, YinMX, HuXM, et al.. A safe, simple and efficient doxorubicin prodrug hybrid micelle for overcoming tumor multidrug resistance and targeting delivery. J Control Release, 2016, 235: 182-194

[39] HouWX, ZhaoX, QianXQ, et al.. pH-Sensitive self-assembling nanoparticles for tumor near-infrared fluorescence imaging and chemo–photodynamic combi-nation therapy. Nanoscale, 2016, 8(1): 104-116

[40] DongK, LeiQY, QiHF, et al.. Amplification of oxidative stress in MCF-7 cells by a novel pH-responsive amphiphilic micellar system enhances anticancer therapy. Mol Pharm, 2019, 16(2): 689-700

[41] LynnDM, LangerR. Degradable poly (β-amino esters): synthesis, characterization, and self-assembly with plasmid DNA. J Am Chem Soc, 2000, 122(44): 10761-10768

[42] KoJY, ParkKS, KimYS, et al.. Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly (β-amino ester) block copolymer micelles for cancer therapy. J Control Release, 2007, 123(2): 109-115

[43] MinKH, KimJH, BaeSM, et al.. Tumoral acidic pH-responsive MPEG-poly (β-amino ester) polymeric micelles for cancer targeting therapy. J Control Release, 2010, 144(2): 259-266

[44] ChenYC, BathulaSR, LiJ, et al.. Multifunctional nanoparticles delivering small interfering RNA and doxorubicin overcome drug resistance in cancer. J Biol Chem, 2010, 285(29): 22639-22650

[45] ZhaoS, TanSW, GuoYY, et al.. pH-sensitive docetaxel-loaded d-α-tocopheryl polyethylene glycol succinate–poly (β-amino ester) copolymer nanoparticles for over-coming multidrug resistance. Biomacromolecules, 2013, 14(8): 2636-2646

[46] ZhangJM, LiJJ, ShiZ, et al.. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities. Acta Biomater, 2017, 58: 349-364

[47] LiZ, QiuLP, ChenQ, et al.. pH-sensitive nanoparticles of poly (L-histidine)-poly (lactide-co-glycolide)-tocopheryl polyethylene glycol succinate for anti-tumor drug delivery. Acta Biomater, 2015, 11: 137-150

[48] HuM, ChenJY, LiZY, et al.. Gold nanostructures: engineering their plasmonic properties for biomedical applications. Chem Soc Rev, 2006, 35(11): 1084-1094

[49] XingRR, LiuK, JiaoTF, et al.. An injectable self-assembling collagen-gold hybrid hydrogel for combinatorial antitumor photothermal/photodynamic therapy. Adv Mater, 2016, 28(19): 3669-3676

[50] KankalaRK, LiuCG, ChenAZ, et al.. Overcoming multidrug resistance through the synergistic effects of hierarchical pH-sensitive, ROS-generating nanoreactors. ACS Biomater Sci Eng, 2017, 3(10): 2431-2442

[51] Small, 2017, 13(29):

[52] GuissiNEI, LiHP, XuYR, et al.. Mitoxantrone-and folate-TPGS2K conjugate hybrid micellar aggregates to circumvent toxicity and enhance efficiency for breast cancer therapy. Mol Pharm, 2017, 14(4): 1082-1094

[53] ZhangJL, ZhaoXF, ChenQ, et al.. Systematic evaluation of multifunctional paclitaxel-loaded polymeric mixed micelles as a potential anticancer remedy to overcome multidrug resistance. Acta Biomater, 2017, 50: 381-395

[54] KuppusamyP, LiHQ, IlangovanG, et al.. Noninvasive imaging of tumor redox status and its modification by tissue glutathione levels. Cancer Res, 2002, 62(1): 307-312

[55] DengB, MaP, XieY. Reduction-sensitive polymeric nanocarriers in cancer therapy: a comprehensive review. Nanoscale, 2015, 7(30): 12773-12795

[56] RastewE, VicenteJB, SinghU. Oxidative stress resistance genes contribute to the pathogenic potential of the anaerobic protozoan parasite, Entamoeba histolytica. Int J Parasit, 2012, 42(11): 1007-1015

[57] RahmanI. Oxidative stress, chromatin remodeling and gene transcription in inflammation and chronic lung diseases. J Biochem Mol Biol, 2003, 36(1): 95-109

[58] VaccariL, CantonD, ZaffaroniN, et al.. Porous silicon as drug carrier for controlled delivery of doxorubicin anticancer agent. Microelectron Eng, 2006, 83(4-9): 1598-1601

[59] WeiH, ZhuoRX, ZhangXZ. Design and development of polymeric micelles with cleavable links for intracellular drug delivery. Prog Polym Sci, 2013, 38(3-4): 503-535

[60] LeeMH, YangZG, LimCW, et al.. Disulfide-cleavage-triggered chemosensors and their biological applications. Chem Rev, 2013, 113(7): 5071-5109

[61] BrülisauerL, GauthierMA, LerouxJC. Disulfide-containing parenteral delivery systems and their redox-biological fate. J Control Release, 2014, 195: 147-154

[62] BaoYL, GuoYY, ZhuangXT, et al.. D-α-tocopherol polyethylene glycol succinate-based redox-sensitive paclitaxel prodrug for overcoming multidrug resistance in cancer cells. Mol Pharm, 2014, 11(9): 3196-3209

[63] QiaoHZ, ZhuZZ, FangD, et al.. Redox-triggered mitoxantrone prodrug micelles for overcoming multidrug-resistant breast cancer. J Drug Target, 2018, 26(1): 75-85

[64] BanalaVT, UrandurS, SharmaS, et al.. Targeted co-delivery of the aldose reductase inhibitor epalrestat and chemotherapeutic doxorubicin via a redox-sensitive prodrug approach promotes synergistic tumor suppression. Biomater Sci, 2019, 7(7): 2889-2906

[65] DongK, YanY, WangPC, et al.. Biodegradable mixed MPEG-SS-2SA/TPGS micelles for triggered intracellular release of paclitaxel and reversing multidrug resistance. Int J Nanomed, 2016, 11: 5109

[66] GuoYY, NiuBN, SongQL, et al.. RGD-decorated redox-responsive d-α-tocopherol polyethylene glycol succinate–poly (lactide) nanoparticles for targeted drug delivery. J Mat Chem B, 2016, 4(13): 2338-2350

[67] WangL, XieX, LiuD, et al.. iRGD-mediated reduction-responsive DSPE–PEG/LA–PLGA–TPGS mixed micelles used in the targeted delivery and triggered release of docetaxel in cancer. RSC Adv, 2016, 6(34): 28331-28342

[68] SongQL, TanSW, ZhuangXT, et al.. Nitric oxide releasing D-α-tocopheryl polyethylene glycol succinate for enhancing antitumor activity of doxorubicin. Mol Pharm, 2014, 11(11): 4118-4129

[69] YinMX, TanSW, BaoYL, et al.. Enhanced tumor therapy via drug co-delivery and in situ vascular-promoting strategy. J Control Release, 2017, 258: 108-120

[70] QiY, QinXY, YangCL, et al.. Micelle system based on molecular economy principle for overcoming multidrug resistance and inhibiting metastasis. Mol Pharm, 2018, 15(3): 1005-1016

[71] XuCF, SunY, QiY, et al.. Selective self-induced stimulus amplification prodrug platform for inhibiting multidrug resistance and lung metastasis. J Control Release, 2018, 284: 224-239

[72] SuZG, ChenML, XiaoYY, et al.. ROS-triggered and regenerating anticancer nanosystem: An effective strategy to subdue tumor’s multidrug resistance. J Control Release, 2014, 196: 370-383

[73] ZhangXY, WangXF, ZhongWT, et al.. Matrix metalloproteinases-2/9-sensitive peptide-conjugated polymer micelles for site-specific release of drugs and enhancing tumor accumulation: preparation and in vitro and in vivo evaluation. Int J Nanomed, 2016, 11: 1643

[74] ZhaoH, JingMF, LiZH, et al.. Potentiating chemotherapy efficacy in neuroblastoma cells via disialoganglioside2 targeting mixed micelles. J Nanosci Nanotechnol, 2016, 16(12): 12307-12315

[75] GaoL, WangXQ, MaJL, et al.. Evaluation of TPGS-modified thermo-sensitive Pluronic PF127 hydrogel as a potential carrier to reverse the resistance of P-gp-overexpressing SMMC-7721 cell lines. Colloid Surf B: Biointerfaces, 2016, 140: 307-316

[76] RapoportN. Physical stimuli-responsive polymeric micelles for anti-cancer drug delivery. Prog Polym Sci, 2007, 32(8-9): 962-990

[77] ZhangQS, ZhaLS, MaJH, et al.. A novel route to prepare pH-and temperature-sensitive nanogels via a semibatch process. J Colloid Interface Sci, 2009, 330(2): 330-336

[78] GuoM, YanY, ZhangHK, et al.. Magnetic and pH-responsive nanocarriers with multilayer core–shell architecture for anticancer drug delivery. J Mater Chem, 2008, 18(42): 5104-5112

[79] FengHK, ZhaoY, PelletierM, et al.. Synthesis of photo-and pH-responsive composite nanoparticles using a two-step controlled radical polymerization method. Polymer, 2009, 50(15): 3470-3477

[80] IsojimaT, LattuadaM, VanderSJB, et al.. Reversible clustering of pH-and temperature-responsive Janus magnetic nanoparticles. Acs Nano, 2008, 2(9): 1799-1806

[81] BaoYL, KongM, GaoXQ, et al.. pH-, redox dual-sensitive poly (β-amino ester)-g-TPGS copolymer nanoparticles for drug delivery and inhibition of multidrug resistance in cancer. React Funct Polym, 2017, 120: 131-138

[82] YinMX, BaoYL, GaoXQ, et al.. Redox/pH dual-sensitive hybrid micelles for targeting delivery and overcoming multidrug resistance of cancer. J Mat Chem B, 2017, 5(16): 2964-2978

[83] HanN, ZhaoQF, WanL, et al.. Hybrid lipid-capped mesoporous silica for stimuli-responsive drug release and overcoming multidrug resistance. ACS Appl Mater Interfaces, 2015, 7(5): 3342-3351

[84] ShaLP, ZhaoQF, WangD, et al.. “Gate” engineered mesoporous silica nanoparticles for a double inhibition of drug efflux and particle exocytosis to enhance antitumor activity. J Colloid Interface Sci, 2019, 535: 380-391

[85] ChengR, MengFH, DengC, et al.. Dual and multi-stimuli responsive polymeric nanoparticles for progra-mmed site-specific drug delivery. Biomaterials, 2013, 34(14): 3647-3657